Moore Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-52,400
Closed -$3.04M 325
2018
Q2
$3.04M Buy
+52,400
New +$2.96M 0.07% 162
2014
Q1
Sell
-524,000
Closed -$25M 508
2013
Q4
$25M Sell
524,000
-762,944
-59% -$34.9M 0.39% 50
2013
Q3
$58.5M Sell
1,286,944
-890,800
-41% -$40.7M 1.24% 13
2013
Q2
$96.5M Buy
+2,177,744
New +$97.3M 2.32% 9

Other funds holding MRK

Moore Capital Management's MRK Position: Q3 2025 in Review

Moore Capital Management sold out of Merck (MRK) in Q3 2025, closing a stake of 43,074 shares — an estimated $3.41M sold.

Moore Capital Management first reported a position in MRK in Q4 2013 and held it in 7 quarters. The position peaked at $15.3M in Q4 2023. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Moore Capital Management reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
  • Moore Capital Management sold 43,074 Merck shares in Q3 2025, an estimated $3.41M.
  • Moore Capital Management first reported a position in Merck in Q4 2013 and held it in 7 quarters.
  • Moore Capital Management's Merck position peaked at $15.3M in Q4 2023.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Moore Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.